USP27 promotes its stability by interacting with SETD3 and accelerates the growth of hepatoma tumor cells, and higher expression of USP27 and SETD3 predicts poorer survival in HCC patients (163). This evidence concerns the gene SETD3 and hepatocellular carcinoma.